1887

Abstract

This paper aims to evaluate the antimicrobial resistance of isolates from children under 5 years old, with and without diarrhoea, who were hospital outpatients in Culiacan, Sinaloa, Mexico. It also looks at the antimicrobial activity of fruit extracts against selected multidrug-resistant (MDR) strains.

A total of 205 isolates from stool samples were collected from 94 children under 5 years old who were outpatients from two hospitals in the city of Culiacan, Sinaloa, Mexico, during the autumn/winter of 2003/04; their resistance profiles to 19 commercial antimicrobials were investigated using the Kirby–Bauer method. The antibacterial activities of extracts/fractions of fruits (i.e. uvalama, ; ayale, ; and arrayan, ) were evaluated using the broth microdilution method.

All isolates were susceptible to amikacin, nitrofurantoin and meropenem, and approximately 96 % were resistant to at least one antimicrobial, especially carbenicillin (93.2 %), cefuroxime sodium (53.7 %), ampicillin (40 %) and trimethoprim/sulfamethoxazole (35.1 %). Likewise, the frequency of MDR strains (44.9 %) was high, and no significant association with diarrhoea symptoms was found. Remarkably, all fruit extracts/fractions showed antibacterial activity against some, but not all, MDR isolates. The lowest minimal inhibitory concentration values were for the hexane fraction of arrayan (0.25 mg ml).

A high number of antimicrobial-resistant (especially to β-lactams and sulfonamides) and MDR isolates were detected in children under 5 years old, irrespective of diarrhoea symptoms; this is novel information for Culiacan, Sinaloa, Mexico. Moreover, our results showed that the studied fruit extracts/fractions are potential alternative or complementary treatments for MDR strains.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000548
2017-07-01
2020-01-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/7/972.html?itemId=/content/journal/jmm/10.1099/jmm.0.000548&mimeType=html&fmt=ahah

References

  1. WHO 2016; Diarrhoeal disease. Fact sheet N°330, April 2013. World Health Organizationwww.who.int/mediacentre/factsheets/fs330/en/ [accessed 23 September 2016]
  2. SINAVE/DGE/SALUD Panorama Epidemiológico y Estadístico de la Mortalidad por Causas Sujetas a Vigilancia Epidemiológica en México 2013 Mexico: Secretaría de Salud; 2016
    [Google Scholar]
  3. Guerra JA, Romero-Herazo YC, Arzuza O, Gómez-Duarte OG. Phenotypic and genotypic characterization of enterotoxigenic Escherichia coli clinical isolates from northern Colombia, South America. Biomed Res Int 2014;2014:1–11 [CrossRef][PubMed]
    [Google Scholar]
  4. Haghi F, Zeighami H, Hajiahmadi F, Khoshvaght H, Bayat M. Frequency and antimicrobial resistance of diarrhoeagenic Escherichia coli from young children in Iran. J Med Microbiol 2014;63:427–432 [CrossRef][PubMed]
    [Google Scholar]
  5. Amábile-Cuevas C. Antibiotic resistance in Mexico: a brief overview of the current status and its causes. J Infect Dev Ctries 2010;4:126–131 [CrossRef][PubMed]
    [Google Scholar]
  6. Pons MJ, Mosquito S, Ochoa TJ, Vargas M, Molina M et al. Niveles de resistencia a antimicrobianos, en especial a quinolonas, en cepas de Escherichia coli comensales en niños de la zona periurbana de Lima, Perú. Rev Peru Med Exp Salud Publica 2012;29:82–86[CrossRef]
    [Google Scholar]
  7. WHO Antimicrobial Resistance Global Report on Surveillance France: 2014
    [Google Scholar]
  8. Dyar OJ, Hoa NQ, Trung NV, Phuc HD, Larsson M et al. High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam. BMC Infect Dis 2012;12:1–8 [CrossRef][PubMed]
    [Google Scholar]
  9. Nakhjavani FA, Emaneini M, Hosseini H, Iman-Eini H, Aligholi M et al. Molecular analysis of typical and atypical enteropathogenic Escherichia coli (EPEC) isolated from children with diarrhoea. J Med Microbiol 2013;62:191–195 [CrossRef][PubMed]
    [Google Scholar]
  10. Pitondo-Silva A, Nakazato G, Falcão JP, Irino K, Martinez R et al. Phenotypic and genetic features of enteropathogenic Escherichia coli isolates from diarrheal children in the Ribeirão Preto metropolitan area, São Paulo State, Brazil. APMIS 2015;123:128–135 [CrossRef][PubMed]
    [Google Scholar]
  11. Shakya P, Barrett P, Diwan V, Marothi Y, Shah H et al. Antibiotic resistance among Escherichia coli isolates from stool samples of children aged 3 to 14 years from Ujjain, India. BMC Infect Dis 2013;13:1–6 [CrossRef][PubMed]
    [Google Scholar]
  12. Garcia PG, Silva VL, Diniz CG. Occurrence and antimicrobial drug susceptibility patterns of commensal and diarrheagenic Escherichia coli in fecal microbiota from children with and without acute diarrhea. J Microbiol 2011;49:46–52 [CrossRef][PubMed]
    [Google Scholar]
  13. Alanís AD, Calzada F, Cervantes JA, Torres J, Ceballos GM. Antibacterial properties of some plants used in Mexican traditional medicine for the treatment of gastrointestinal disorders. J Ethnopharmacol 2005;100:153–157 [CrossRef][PubMed]
    [Google Scholar]
  14. UNAM Biblioteca Digital de la Medicina Tradicional Mexicana México: Universidad Nacional Autónoma de México; 2009;www.medicinatradicionalmexicana.unam.mx/termino.php?l=1&t=diarrea&letra=D&opcion=D&id=2968 [accessed 29 Augustus 2016]
    [Google Scholar]
  15. SEMARNAT Informe de la Situación del Medio Ambiente en México. Edición 2008. Compendio de Estadísticas Ambientales México, DF: Dirección General de Estadística e Información Ambiental. Secretaría del Medio Ambiente y Recursos Naturales; 2008
    [Google Scholar]
  16. Delgado-Vargas F, Félix-Favela F, Pío-León J, López-Angulo G, López-Valenzuela J et al. Antibacterial activity and qualitative phytochemical analysis of Vitex mollis fruit. Int J Green Pharm 2010;4:288 [CrossRef]
    [Google Scholar]
  17. Pío-León JF, López-Angulo G, Paredes-López O, Uribe-Beltrán MJ, Díaz-Camacho SP et al. Physicochemical, nutritional and antibacterial characteristics of the fruit of Bromelia pinguin L. Plant Foods Hum Nutr 2009;64:181–187 [CrossRef][PubMed]
    [Google Scholar]
  18. Ahumada-Santos YP, Soto-Sotomayor ME, Báez-Flores ME, Díaz-Camacho SP, López-Angulo G et al. Antibacterial synergism of Echeveria subrigida (B. L. Rob & Seaton) and commercial antibiotics against multidrug resistant Escherichia coli and Staphylococcus aureus. Eur J Integr Med 2016;8:638–644 [CrossRef]
    [Google Scholar]
  19. Pío-León JF, Díaz-Camacho SP, López-López MA, Uribe-Beltrán M de J, Willms K et al. Actividad antibacteriana de extractos de frutos de nanchi (Byrsonima crassifolia (L.) Kunth), arrayán (Psidium sartorianum (O. Berg) Nied.) y ayale (Crescentia alata Kunth). Bol Latinoam Caribe Plantas Medicinales Aromat 2013;12:356–364
    [Google Scholar]
  20. CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard, 6th ed. CLSI document M07-A9 ed Wayne, PA: Clinical and Laboratory Standards Institute; 2012; p.68
    [Google Scholar]
  21. Işeri L, Zafer Apan T, Aksoy A, Koç F, Sedef Göçmen J et al. The prevalence of enterotoxigenic E. coli isolated from the stools of children aged 0-10 years with diarrhea in mid-Anatolia region, Turkey. Braz J Microbiol 2011;42:243–247 [CrossRef][PubMed]
    [Google Scholar]
  22. Wall ME, Wani MC, Brown DM, Fullas F, Olwald JB et al. Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytomedicine 1996;3:281–285 [CrossRef][PubMed]
    [Google Scholar]
  23. CLSI Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100S Wayne, PA: Clinical and Laboratory Standards Institute; 2016
    [Google Scholar]
  24. Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis 2011;15:e136e139 [CrossRef][PubMed]
    [Google Scholar]
  25. Tian L, Zhu X, Chen Z, Liu W, Li S et al. Characteristics of bacterial pathogens associated with acute diarrhea in children under 5 years of age: a hospital-based cross-sectional study. BMC Infect Dis 2016;16:253 [CrossRef][PubMed]
    [Google Scholar]
  26. Bryce A, Costelloe C, Hawcroft C, Wootton M, Hay AD. Faecal carriage of antibiotic resistant Escherichia coli in asymptomatic children and associations with primary care antibiotic prescribing: a systematic review and meta-analysis. BMC Infect Dis 2016;16:359 [CrossRef][PubMed]
    [Google Scholar]
  27. Novoa-Farías O, Frati-Munari A, Peredo M, Flores-Juárez S, Novoa-García O et al. Susceptibilidad de las bacterias aisladas de infecciones gastrointestinales agudas a la rifaximina y otros agentes antimicrobianos en México. Rev Gastroenterol Mex 2016;81:3–10
    [Google Scholar]
  28. Rodríguez-Noriega E, León-Garnica G, Petersen-Morfín S, Pérez-Gómez HR, González-Díaz E et al. La evolución de la resistencia bacteriana en México, 1973-2013. Biomédica 2013;34:181–190[CrossRef]
    [Google Scholar]
  29. Salazar-Holguín HD, Cisneros-Robledo ME. Resistencia a los antimicrobianos de agentes causales de las principales infecciones nosocomiales. Rev Med Inst Mex Seguro Social 2016;54:462–471
    [Google Scholar]
  30. A, Alcántar-Curiel MD, Jiménez-Galicia C, Rios-Sarabia N, Pacheco S et al. Antibiotic resistance of Gram-negative bacilli isolated from pediatric patients with nosocomial bloodstream infections in a Mexican tertiary care hospital. Chemotherapy 2014;59:361–368
    [Google Scholar]
  31. Morfin-Otero R, Noriega ER, Dowzicky MJ. Antimicrobial susceptibility trends among Gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial. Ann Clin Microbiol Antimicrob 2015;14:1 [CrossRef][PubMed]
    [Google Scholar]
  32. Morfin-Otero R, Tinoco-Favila JC, Sader HS, Salcido-Gutierrez L, Perez-Gomez HR et al. Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010. BMC Res Notes 2012;5:277 [CrossRef][PubMed]
    [Google Scholar]
  33. Romero RM, Acosta DDM, Ortega AB. Prevalencia y resistencia antimicrobiana de microorganismos aislados en el Centro Oncológico Estatal del ISSEMYM. Rev Latinoam Patol Clin Med Lab 2013;60:244–251
    [Google Scholar]
  34. Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American countries, 1997–2007. Rev Panam Salud Publica 2010;27:219–225 [CrossRef][PubMed]
    [Google Scholar]
  35. Mohammad A. Antimicrobial susceptibility of Escherichia coli isolates from clinical specimens in children over a 5-Year period in Jordan. Biomed Pharmacol J 2016;9:09–13 [CrossRef]
    [Google Scholar]
  36. Guzmán-Blanco M, Labarca JA, Villegas MV, Gotuzzo E.Latin America Working Group on Bacterial Resistance Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis 2014;18:421–433 [CrossRef][PubMed]
    [Google Scholar]
  37. Gibbons S. Anti-staphylococcal plant natural products. Nat Prod Rep 2004;21:263–277 [CrossRef][PubMed]
    [Google Scholar]
  38. Wang D, He F, Lv Z, Li D. Phytochemical composition, antioxidant activity and HPLC fingerprinting profiles of three Pyrola species from different regions. PLoS One 2014;9:e96329 [CrossRef][PubMed]
    [Google Scholar]
  39. Walker TS. Microbiologia Philadelphia, PA: McGraw-Hill Interamericana; 2000
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000548
Loading
/content/journal/jmm/10.1099/jmm.0.000548
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error